MAPT and frontotemporal dementia: iPSC-derived cerebral organoids expressing a MAPT mutation (tau-V337M) have been used to model early FTD pathogenesis; the resulting models include alterations in the expression of MAPT and ELAVL4, alterations in glutamatergic signaling, increased stress granules, and disruption of autophagy mechanisms.